Gam-Covid-Vak vaccine ampoule («Sputnik V»). File photoBUENOS AIRES, Apr 26 Richmond Lab, which produces the Russian Sputnik V vaccine in Argentina, continues to prepare to launch a plant to produce the drug from scratch, Clarín newspaper reported, citing sources.»O project to produce Sputnik V from scratch, as well as other vaccines, in a new plant that the laboratory is building, the source said that «technology transfer activities have not been suspended, the plant will be launched in October-November of this year,» the source said. Richmond is working on technology transfer for the production of coronavirus vaccines not only with Russia, but also with the United States, Europe and Asia. In addition, newspaper sources said that the laboratory currently has 1.4 million doses of the Russian vaccine in stock, however, they so far remain unclaimed by the country's authorities, since Argentina has enough drugs to immunize the population. The head of the laboratory, Marcelo Figueras, told RIA Novosti in September last year that Richmond will launch a new plant in a year, where the Russian coronavirus drug will be made from scratch. Currently, the active substance for the production of the vaccine is supplied from Russia. In addition, this new plant will also be able to produce RNA vaccines. The venture will cost $65 million. The plant's capacity will be 500 million doses per year.
EMA: Expertise of the Russian Sputnik V vaccine continues
